Earnings Feed
Start Free
Home/Insiders/Sachs David C.
SD
SEC Insider//CIK 0001848899

Sachs David C.

CIK 00018488991 companySAN DIEGO, CA
SEC Profile

Transactions

30

Companies

1

Filings

8

CIK

0001848899

Recent Transactions

30 trades
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2025-12-31−30,397→ 45,602 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2025-12-31+30,397→ 256,017 total
  • Tax Payment
    ImmunityBio, Inc.$IBRX

    Common Stock

    2025-12-31$1.98/sh−15,435→ 240,582 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2025-02-22−40,650→ 81,301 total
  • Tax Payment
    ImmunityBio, Inc.$IBRX

    Common Stock

    2025-02-22$3.42/sh−15,860→ 225,620 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2025-02-22+40,650→ 241,480 total
  • Award
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2025-02-10+246,710→ 246,710 total
  • Award
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2025-02-10+843,750→ 843,750 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2024-12-31+30,397→ 216,235 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2024-12-31−30,397→ 75,999 total
  • Tax Payment
    ImmunityBio, Inc.$IBRX

    Common Stock

    2024-12-31$2.56/sh−15,405→ 200,830 total
  • Award
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2024-02-22+424,390→ 424,390 total
  • Award
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2024-02-22+121,951→ 121,951 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2024-01-31−70,745→ 0 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2024-01-31+70,745→ 212,673 total
  • Tax Payment
    ImmunityBio, Inc.$IBRX

    Common Stock

    2024-01-31$3.36/sh−26,835→ 185,838 total
  • Tax Payment
    ImmunityBio, Inc.$IBRX

    Common Stock

    2023-12-31$5.02/sh−10,511→ 141,928 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2023-12-31−30,397→ 106,396 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2023-12-31+30,397→ 152,439 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2023-09-01−70,744→ 70,745 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2023-09-01+70,744→ 122,042 total
  • Award
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2023-08-25+141,489→ 141,489 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2022-12-31−7,598→ 136,793 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2022-12-31+7,598→ 51,298 total
  • Award
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2022-03-23+125,000→ 125,000 total
  • Award
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2022-03-23+125,000→ 125,000 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2021-12-09+17,242→ 43,700 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2021-12-09−17,242→ 144,391 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Restricted Stock Units

    2021-09-09−7,598→ 161,633 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2021-09-09+7,598→ 26,458 total

Companies

1

Recent Filings

8

Address

C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121

View on SEC.gov